Login / Signup

Activity and Effectiveness of Recombinant hEGF Excreted by Escherichia coli BL21 on Wound Healing in Induced Diabetic Mice.

Sriwidodo SriwidodoIman Permana MaksumToto SubrotoNasrul WathoniAnas SubarnasAbd Kakhar Umar
Published in: Journal of experimental pharmacology (2020)
Recombinant hEGF produced by extracellular secretion using E. coli BL21 has optimal diabetic wound healing activity through increased fibroblast proliferation.
Keyphrases
  • wound healing
  • escherichia coli
  • randomized controlled trial
  • systematic review
  • high glucose
  • signaling pathway
  • cell free
  • staphylococcus aureus
  • klebsiella pneumoniae
  • drug induced
  • pseudomonas aeruginosa